DrJoan Ni Gabhann-Dromgoole

Senior Lecturer

School of Pharmacy and Biomolecular Sciences

  • Senior Lecturer
    School of Pharmacy and Biomolecular Sciences
  • 01 4025216 (Work)
  • RCSI, Molecular & Cellular Therapeutics, 123 St Stephens Green, Dublin 2

RESEARCH OVERVIEW

Our research program is targeting the underlying pathology the autoimmune disease Sjogren’s Syndrome (SS), which gives rise to dry eyes and dry mouth through reduced exocrine gland function, as well as contributing to a range of extra glandular complications. These complications can range in severity from fatigue to the development of pulmonary fibrosis, interstitial lung disease and in certain cases, non-Hodgkin’s lymphoma. There are no effective therapies for SS or diagnostic tests that allow identification of patients who will go on to develop further complications. Our work aims to address this need through targeting the molecular mechanisms that underpin SS development and pathogenesis. Recently our research has focussed on investigating the role of non-coding microRNAs that regulate inflammation, and in particular pathogenic cytokine production, to the pathogenesis of SS. Given the critically important role of inflammation and dysregulated inflammatory cytokine production in a variety of autoimmune conditions and dry eye diseases our research also aims to delineate a role for these novel regulatory molecules in inflammatory diseases with the hope of identifying new therapeutic targets and diagnostics.
Our group successfully operates within a clinician-scientist framework, thus we are uniquely positioned within RCSI and the Royal Victoria Eye and Ear Hospital to investigate the immunological component to a range of ocular surface diseases. The clinical lead in our group, Prof Conor Murphy, Professor of Ophthalmology, has established research interests in the areas of uveitis, herpes simplex keratitis and dry eye disease (DED). We currently focus on DED particularly in the context of the autoimmune condition, SS. However, the underlying inflammatory or immune component across the presentations of DED means that our research will be applicable to a range of conditions including age related dry eye disease, aqueous tear deficiency and potentially graft versus host disease in the context of corneal transplantation.

GRANTS

  • FUNDED PROJECT
    BScATT 2026 Placements
    RCSI29 Jun 2026 - 31 Dec 2026
  • FUNDED PROJECT
    StAR International PhD Programme 2023
    RCSI1 Sep 2023 - 31 Aug 2027
  • FUNDED PROJECT
    Conference Support Funds
    Industry10 May 2023 - 9 May 2028
  • FUNDED PROJECT
    Profiling emerging immune signatures associated with developing inflammatory ocular graft versus host disease and adverse outcomes from corneal transplantation (PREDICT).
    Enterprise Ireland8 Sep 2022 - 7 Sep 2023
  • FUNDED PROJECT
    Multiomic characterization of ocular graft versus host disease from patient tears
    Royal Victoria Eye & Ear Hospital Research Foundation1 Oct 2021 - 30 Sep 2022
  • FUNDED PROJECT
    Collaborate Initiative – IPO
    RCSI1 Sep 2021 - 31 Dec 2024
  • FUNDED PROJECT
    National PPI Network Award
    Health Research Board / HRB1 Mar 2021 - 28 Feb 2026
    People funded by this grant:
    • Sean D,
    • Ruth M,
    • Martin O,
    • Patricia K,
    • Veronica L
  • FUNDED PROJECT
    Establishing a two dimensional and three-dimensional model of inflammatory dry eye disease to test novel therapeutics using primary human conjunctival epithelial cells
    Royal Victoria Eye & Ear Hospital Research Foundation16 Nov 2020 - 31 Jul 2022
  • FUNDED PROJECT
    Multiomic profiling of ocular inflammation in dry eye disease relating to ocular graft versus host disease
    Royal Victoria Eye & Ear Hospital Research Foundation20 Feb 2020 - 31 Mar 2022
  • FUNDED PROJECT
    SSC Research Programme 2020
    RCSI1 Jan 2020 - 31 Mar 2021
  • FUNDED PROJECT
    Establishing a 2D and three-dimensional model of inflammatory dry eye disease to test novel therapeutics using primary human conjunctival epithelial cells’
    Irish College of Opthalmologists - ICO1 Jul 2019 - 31 Jul 2022
  • FUNDED PROJECT
    RCSI Research Summer School 2019
    RCSI12 Apr 2019 - 31 Jan 2022
  • FUNDED PROJECT
    Targeting ocular inflammation in dry eye disease with novel microRNA-based therapeutics
    Royal Victoria Eye & Ear Hospital Research Foundation1 Nov 2018 - 31 Mar 2022
  • FUNDED PROJECT
    Targeting dry eye disease (DED) and ocular graft-versus-host disease (GVHD) with novel microRNA-based therapeutics
    Irish College of Opthalmologists - ICO16 Oct 2018 - 16 Oct 2022
  • FUNDED PROJECT
    Modulating microRNA expression as a means to restore immune function in patients with primary Sjogrens Syndrome
    RCSI1 Jan 2015 - 31 Dec 2015
  • FUNDED PROJECT
    Targeting inflammation in the autoimmune condtions Sjögren’s syndrome and systemic lupus erythematosus –novel microRNAs as potential therapeutics
    Trinity College Dublin24 Mar 2014 - 30 Jun 2014